Frebelius S, Swedenborg J
Department of Experimental Surgery, Karolinska Hospital, Stockholm, Sweden.
Thromb Res. 1987 Jul 15;47(2):223-33. doi: 10.1016/0049-3848(87)90379-3.
One aspect of the non-thrombogenicity of endothelium is the property to bind and inhibit thrombin. Loss of the endothelial layer gives rise to a thrombogenic surface. The present study concerns uptake and inactivation of thrombin on endothelium as well as subendothelium. Both the immediate subendothelial layer and the media were investigated. Binding and inhibition of thrombin was assayed using both a synthetic chromogenic substrate and fibrinogen. In the latter case thrombin enzymatic activity was assessed by measuring liberation of fibrinopeptide A. There was a linear relationship between thrombin in the solution and thrombin enzymatic activity recovered on the surface on both endothelium and media. 30-50 per cent of the surface bound thrombin measured with the chromogenic substrate was also active towards fibrinogen. Preincubation of endothelium with plasma gave rise to an increased loss of thrombin from the solution at the same time as less thrombin was recovered on the surface. This indicates increased inactivation. Increased inactivation could also be obtained by pretreatment with antithrombin (AT) but not with AT-depleted plasma. The same general pattern was seen on the subendothelium but not on the media. It is concluded that inhibition of thrombin occurs on the endothelium and can be augmented by prior binding of AT to the surface. This effect although less pronounced can also be obtained on the subendothelium. The deeply injured vessel is much less capable of inhibiting thrombin.
内皮细胞非血栓形成性的一个方面是其结合并抑制凝血酶的特性。内皮细胞层的缺失会产生一个血栓形成表面。本研究关注内皮细胞以及内皮下层对凝血酶的摄取和失活情况。对紧邻的内皮下层和中层均进行了研究。使用合成生色底物和纤维蛋白原对凝血酶的结合和抑制进行了测定。在后一种情况下,通过测量纤维蛋白肽A的释放来评估凝血酶的酶活性。溶液中的凝血酶与在内皮细胞和中层表面恢复的凝血酶酶活性之间存在线性关系。用生色底物测定的表面结合凝血酶中,有30% - 50%对纤维蛋白原也具有活性。内皮细胞与血浆预孵育会导致溶液中凝血酶损失增加,同时表面恢复的凝血酶减少。这表明失活增加。用抗凝血酶(AT)预处理也可导致失活增加,但用缺乏AT的血浆预处理则不会。在内皮下层观察到相同的总体模式,但在中层未观察到。结论是,凝血酶的抑制发生在内皮细胞上,并且AT预先结合到表面可增强这种抑制作用。这种作用虽然不太明显,但在内皮下层也可观察到。严重受损的血管抑制凝血酶的能力要弱得多。